Get The Free Sample Complete
SWOT & PESTLE Analysis Report
This report is shared in order to give you an idea of what the complete SWOT & PESTLE analysis report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free. You also agree to receive email updates from us on our new reports and solutions.
Get Your Free Summary Copy of the
SWOT & PESTLE Analysis Report
Get the summary SWOT & PESTLE.com report delivered straight to your email inbox for free. Our insightful and holistic reports have helped corporates, academia and researchers take their research forward. You also agree to receive email updates from us on our new reports and solutions.

Eurofins Scientific SWOT & PESTLE Analysis

ID : 52759453| Oct 2020| 15 pages

COMPANY PROFILE -Eurofins Scientific

Business Sector :Pharmaceuticals, Biotechnology

Operating Geography :Luxembourg, Europe, Global

About Eurofins Scientific :

Eurofins Scientific is a life sciences company headquartered in Luxembourg, providing a unique range of analytical testing services to clients across multiple industries, particularly in the field of pharmaceutical, food, environmental, Agriscience, and consumer products. It was founded in 1987 when its founder Gilles Martin purchased the rights to the SNIF-NMR technology, which aimed to verify the origin and purity of several types of food and beverages. In the next 33 years, the company has grown to over 47,000 staff spread over in 900 independent companies in over 50 countries and is currently operating more than 800 laboratories. Eurofins has been one of the fastest-growing in Europe since it went public with an average annual growth exceeding 29% for the last 22 years. The company boasts a portfolio of over 200,000 analytical methods for evaluating the safety, identity, credibility, composition, origin, and purity of biological substances and products. It is also one of the very few companies across the world that provides services for genomics, forensics, advanced material sciences and for supporting clinical studies.
Investing heavily in research and development and providing a wide range of testing methods in the field of biotechnology and analytical chemistry has been the primary focus of Eurofins. It also provides essential services in specialty esoteric and molecular clinical diagnostic testing in Europe and the USA. Significant investments in innovation, Information technology, and logistics and huge sample volumes ensure that customers enjoy high standards of quality at reasonable prices.
The vision of Eurofins states, "To be the Global Leader in Testing for Life" and the company places its core values on the pillars of customer focus, competence and team spirit, quality, and integrity. Eurofins Scientific proudly maintains that the mission of its business is “To contribute to a safer and healthier global ecosystem by providing its clients with innovative and high-quality laboratory, research, and advisory services while creating opportunities for the employees and generating sustainable shareholder value.”

Eurofins Scientific Revenue :


€ 4562.8 million – FY 2019 (Net Cash: € 677.9 million)
€ 3781.1 million – FY 2018 (Net Cash: € 543.9 million)

Competitive Analysis of Eurofins Scientific

SWOT
PESTLE
The SWOT analysis of Eurofins Scientific is presented below:
Strengths
Weaknesses
1. Focus on scientific innovation
2. Well-established global presence
3. Caters to a broad range of customer segment
4. One-Stop-Service provider
5. Creating entry barriers through premium quality service and leveraging internal efficiencies
6. Leader in Non-Invasive Prenatal Testing (NIPT) in Europe
7. Captures scale advantage through Large and spoke laboratories infrastructure
8. Pharma services spanning the entire drug development cycle
1. I.T. infrastructure prone to cyber-attack
2. Impact on operating income due to Covid-19 pandemic
Opportunities
Threats
1. Expanding in Bioanalytical testing market
2. Innovating in clinical diagnostic markets
3. Start-up program represents a significant investment for the future
4. Food testing market enjoys robust growth drivers
1. Changes in the established market
2. Risk from contractor and supplier
3. Highly competitive industry
SWOT & PESTLE (combined)
Complete Report
USD 12.53
*
  • with PayPal
  • with Debit/Credit card
Great quality, Affordable pricing.
Safe and secure payments
On purchase, the report will reach your email inbox within minutes. At rare times, a slight delay not exceeding 4 hours might be caused.

Detailed SWOT Analysis of Eurofins Scientific

 

Strength

This section is available only in the 'Complete Report' on purchase.

Weakness

This section is available only in the 'Complete Report' on purchase.

Opportunity

1. Expanding in Bioanalytical testing market: Bioanalytical testing which can be defined as testing all products and substances that we eat, drink, absorb, swallow, inhale or come in contact with physically is a relatively new market which began expanding significantly only a few decades ago, mainly for third-party service providers. Although the effort is to standardize the whole process, still, the market is highly fragmented, with much smaller and medium-sized laboratories offering a limited technological portfolio, regional presence, and customer reach. Many companies in the bioanalytical testing market are looking forward to providing services. Many countries across the world, have allowed companies to perform laboratory testing mainly restricted to in-house activities.

2. Innovating in clinical diagnostic markets: The clinical diagnostics market mainly consists of assessments, instruments, products, and services that are helpful in the diagnosis and treatment of diseases. This market is expected to grow as effective diagnosis enables the use of more personalized medicine, which involves allowing healthcare professionals to diagnose better and prescribe more definitive treatment for each patient. Technological innovations relevant to medicine can lead to a more accurate diagnosis and treatment of diseases. Furthermore, advances in genomics result in advanced diagnostic tests, which ultimately could bring the healthcare system to a point where personalized medicine can be provided. The amount of healthcare data, including those resulting from modern sequencing technologies, frequently referred to as "next-generation DNA sequencing," and is likely to open up new possibilities to impact diagnosis and treatment of diseases positively.

The remaining section of “Opportunity” is available only in the 'Complete Report' on purchase.

Threat

This section is available only in the 'Complete Report' on purchase.

SWOT & PESTLE (combined)
Complete Report
USD 12.53
*
  • with PayPal
  • with Debit/Credit card
Great quality, Affordable pricing.
Safe and secure payments
On purchase, the report will reach your email inbox within minutes. At rare times, a slight delay not exceeding 4 hours might be caused.

Check Out Analysis of Other Relevant Companies

TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?
References used in Eurofins Scientific Analysis Report

1. Eurofins Scientific Annual report 2019 - https://cdnmedia.eurofins.com/corporate-eurofins/media/12151781/eurofins-2019-annual-report_final.pdf

2. Eurofins Scientific Annual report 2018 - https://cdnmedia.eurofins.com/corporate-eurofins/media/12151781/eurofins-2018-annual-report_final.pdf

3. Eurofins Scientific Company Profile - https://in.reuters.com/finance/stocks/company-profile/EUFI.PA

4. Eurofins Scientific Investor Relations - https://www.eurofins.com/investors/

The detailed complete set of references are available on request in the 'Complete report' on purchase.

How to Reference This Page?

You can use the following in your reference section in order to give credit to the source. For different referencing styles and detailed guidelines, please click here.

Eurofins Scientific SWOT & PESTLE Analysis - SWOT & PESTLE.COM

SWOT & PESTLE.com (2020). Eurofins Scientific SWOT & PESTLE Analysis - SWOT & PESTLE.com. [online] Available at: https://www.swotandpestle.com/eurofins-scientific/ [Accessed 27 Nov, 2020].

In-text: (SWOT & PESTLE.com, 2020)

Copyrights and Disclaimer

Eurofins Scientific SWOT and PESTLE analysis has been conducted by Abhishek Chaku and reviewed by senior analysts from Barakaat Consulting.

Copyright of Eurofins Scientific SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions and Disclaimer for usage guidelines.

You might also like to check out :
Eurofins Scientific SWOT & PESTLE Analysis
Price : USD 12.53